Table 1.

Relationship between H19 and clinicopathological characteristics of PDAC.

		H19 expression
Characteristics	Number of case (n = 25)	Low (n = 8) (%)	High (n = 17) (%)	P value
Age (years)				0.999
<60	12	4(50%)	8(47.06%)
≥60	13	4(50%)	9(52.94%)
Gender				0.999
Male	11	3(37.5%)	8(47.06%)
Female	14	5(62.5%)	9(52.94%)
Tumor size				0.394
<4cm	16	4(50%)	12(70.59%)
≥4 cm	9	4(50%)	5(29.41%)
Location				0.359
Head of pancreas	17	4(50%)	13(76.47%)
Body and tail of pancreas	8	4(50%)	4(23.53%)
Histological grade				0.017
Well and moderate	7	5(62.5%)	2(11.76%)
Poor	18	3(37.5%)	15(88.23%)
Primary tumor				0.081
T1, T2	4	3(37.5%)	1(5.88%)
T3, T4	21	5(62.5%)	16(94.12%)
Lymph node				0.999
N0	17	6(75%)	11(64.71%)
N1	8	2(25%)	6(35.29%)
Venous invasion				0.667
Absent	16	6(75%)	10(58.82%)
Present	9	2(25%)	7(41.18%)
Nervous invasion				0.057
Absent	4	2(25%)	2(11.76%)
Present	21	6(75%)	15(88.24%)
CA19-9				0.999
<37 U/ml	5	1(12.5%)	4(23.53%)
≥37 U/ml	20	7(87.5%)	13(76.47%)
CEA				0.194
<5 ng/ml	15	3(37.5%)	12(70.59%)
≥5 ng/ml	10	5(62.5%)	5(29.41%)